Effect of treatment with peginterferon or interferon alfa‐2b and ribavirin on steatosis in patients infected with hepatitis C
暂无分享,去创建一个
M. Manns | J. Albrecht | Z. Goodman | S. Zeuzem | Z. Younossi | J. McHutchison | T. Poynard | V. Ratziu | J. Mchutchison
[1] Yoshiyuki Suzuki,et al. Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors. , 2002, Journal of hepatology.
[2] J. George,et al. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response , 2002, Hepatology.
[3] C. Grunfeld,et al. Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol , 2002, Hepatology.
[4] K. Bjøro,et al. Effect of Combined Interferon-α Induction Therapy and Ribavirin on Chronic Hepatitis C Virus Infection: a Randomized Multicentre Study , 2002, Scandinavian journal of gastroenterology.
[5] Kenneth Koury,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[6] M. Gambardella,et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity , 2001, Hepatology.
[7] L. Rubbia‐Brandt,et al. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. , 2001, Histopathology.
[8] J. Pawlotsky,et al. Standardization of Hepatitis C Virus RNA Quantification , 2000, Hepatology.
[9] K. Abid,et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. , 2000, Journal of hepatology.
[10] A. Czaja,et al. Host- and disease-specific factors affecting steatosis in chronic hepatitis C , 1998 .
[11] A. Czaja,et al. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. , 1998, Journal of hepatology.
[12] A. Fayyazi,et al. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype , 1997, Hepatology.
[13] M. Kohara,et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Bedossa,et al. An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.
[15] P. Najarro,et al. Inhibition of Mitochondrial Function by Interferon* , 1996, The Journal of Biological Chemistry.
[16] P. Schmid,et al. Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin , 1994, Journal of gastroenterology and hepatology.
[17] P. Bedossa,et al. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .
[18] L. Stuyver,et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. , 1993, The Journal of general virology.
[19] E. Schiff,et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. , 1993, Gastroenterology.
[20] H. Margolis,et al. Histopathology of community acquired chronic hepatitis C. The Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[21] F. Schaffner,et al. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis , 1992, Hepatology.
[22] John D. McKenzie,et al. Number Cruncher Statistical Systems (NCSS) , 1985 .
[23] O. Chazouilleres,et al. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. , 2001, Journal of hepatology.
[24] D. Pessayre,et al. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. , 1997, Journal of hepatology.